Breast Cancer Clinical Trials
Breast Cancer Clinical Trials
We’re here for you. Call us at 844-346-7222 or
Clinical Trials for Breast Cancer Treatments
Since 1989, breast cancer death rates have been decreasing thanks to advancements in treatment and earlier detection. At Regional Cancer Care Associates, we’re proud to be pioneers in the improvement of breast cancer treatments through our clinical trials. If you’re interested in enrolling in a breast cancer clinical trial, call RCCA today at 201-669-4706.
What Are Clinical Trials?
Before a new drug, medical strategy, or device can be approved, it first must be evaluated for human use. This research process is called a clinical trial. As scientific studies, clinical trials are methodically designed to follow strict scientific standards. At the end of each trial, the data is used to determine if the new medical therapy is a safe and effective method for improving patient outcomes.
Why Should I Enroll in a Breast Cancer Clinical Trial?
If you’ve been diagnosed with breast cancer, a clinical trial can give you access to the latest advancements and innovations in treatment methods and medications. In turn, you’ll participate in a research process that may one day help improve the quality of life for thousands of women and men around the world.
It’s important to note that clinical trials are one of the final stages of a careful research process that’s been developed and tested in laboratories for a significant amount of time before being offered to humans. For your safety, all clinical trials are closely monitored by an institutional review board and scientific experts.
Before agreeing to enroll in a breast cancer clinical trial, RCCA specialists require informed consent. This means that you’ll receive in-depth information about the trial, including treatments being used, its purpose, and possible risks and benefits, prior to enrollment. And as far as the cost of care goes, you won’t need to pay a penny. The company sponsoring the clinical trial will cover the bill, making clinical trials an affordable option for those diagnosed with breast cancer.
Breast Cancer Clinical Trials at RCCA
Your wellness and safety is placed above all else at RCCA. That’s why our clinical trials start with a personalized plan. To learn if you’re a good candidate for a breast cancer clinical trial, schedule an appointment with an RCCA cancer care physician today.
find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at (201) 518-3587, or email us at email.
Endocrine disruptors, obesity, and breast density among perimenopausal women
Learn MoreElacestrant versus Standard Endocrine Therapy in Women and Men with Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast Cancer with High Risk of Recurrence – A Global, Multicenter, Randomized, Open-label Phase 3 Study (ELEGANT)
Learn MoreOPTIMICE-PCR: DE-ESCALATION OF THERAPY IN EARLY-STAGE TNBC PATIENTS WHO ACHIEVE PCR AFTER NEOADJUVANT CHEMOTHERAPY WITH CHECKPOINT INHIBITOR THERAPY
Learn MoreA Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Inavolisib in Combination with Phesgo Versus Placebo in Combination with Phesgo as Maintenance Therapy After First Line Induction Therapy in Participants with PIK3CA Mutated HER2 Positive Locally Advanced or Metastatic Breast Cancer
Learn MoreLOTAM: A RANDOMIZED, PHASE III CLINICAL TRIAL OF LOW-DOSE TAMOXIFEN FOR SELECTED PATIENTS WITH MOLECULAR LOW-RISK EARLY-STAGE BREAST CANCER
Learn MoreShortStop-HER2: Shortened Duration of Adjuvant Therapy in Patients with Early-Stage HER2+ Breast Cancer Who Achieve pCR After Neoadjuvant Chemotherapy with HER2 Blockade
Learn MoreWe are here for you
For more information or to schedule an appointment, call (844) 346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.